Vera Therapeutics (VERA) stock falls as Otsuka (OTSKF) updates on its IgA nephropathy therapy sibeprenlimab, which rivals ...
Aker ASA Q4 2024 highlights strategic divestments, dividend growth, and operational efficiency. Discover strong Aker BP production & Cognite momentum.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback